These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

228 related items for PubMed ID: 9785275

  • 1. The nocturnal secretion of cardiac natriuretic peptides during obstructive sleep apnoea and its response to therapy with nasal continuous positive airway pressure.
    Kita H, Ohi M, Chin K, Noguchi T, Otsuka N, Tsuboi T, Itoh H, Nakao K, Kuno K.
    J Sleep Res; 1998 Sep; 7(3):199-207. PubMed ID: 9785275
    [Abstract] [Full Text] [Related]

  • 2. Effects of treatment with nasal continuous positive airway pressure on atrial natriuretic peptide and arginine vasopressin release during sleep in patients with obstructive sleep apnoea.
    Krieger J, Follenius M, Sforza E, Brandenberger G, Peter JD.
    Clin Sci (Lond); 1991 May; 80(5):443-9. PubMed ID: 1851683
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Plasma brain natriuretic peptide in obstructive sleep apnea.
    Svatikova A, Shamsuzzaman AS, Wolk R, Phillips BG, Olson LJ, Somers VK.
    Am J Cardiol; 2004 Aug 15; 94(4):529-32. PubMed ID: 15325948
    [Abstract] [Full Text] [Related]

  • 7. Atrial natriuretic peptide release during sleep in patients with obstructive sleep apnoea before and during treatment with nasal continuous positive airway pressure.
    Krieger J, Laks L, Wilcox I, Grunstein RR, Costas LJ, McDougall JG, Sullivan CE.
    Clin Sci (Lond); 1989 Oct 15; 77(4):407-11. PubMed ID: 2530023
    [Abstract] [Full Text] [Related]

  • 8. Reduction of nocturnal diuresis and natriuresis during treatment of obstructive sleep apnea (OSA) with nasal continuous positive air pressure (nCPAP) correlates to cGMP excretion.
    Ehlenz K, Firle K, Schneider H, Weber K, Peter JH, Kaffarnik H, von Wichert P.
    Med Klin (Munich); 1991 Jun 15; 86(6):294-6, 332. PubMed ID: 1653395
    [Abstract] [Full Text] [Related]

  • 9. Nasal continuous positive airway pressure with supplemental oxygen in coexistent sleep apnoea-hypopnoea syndrome and severe chronic obstructive pulmonary disease.
    Sampol G, Sagalés MT, Roca A, de la Calzada MD, Bofill JM, Morell F.
    Eur Respir J; 1996 Jan 15; 9(1):111-6. PubMed ID: 8834343
    [Abstract] [Full Text] [Related]

  • 10. Plasma leptin levels and cardiac sympathetic function in patients with obstructive sleep apnoea-hypopnoea syndrome.
    Shimizu K, Chin K, Nakamura T, Masuzaki H, Ogawa Y, Hosokawa R, Niimi A, Hattori N, Nohara R, Sasayama S, Nakao K, Mishima M, Nakamura T, Ohi M.
    Thorax; 2002 May 15; 57(5):429-34. PubMed ID: 11978920
    [Abstract] [Full Text] [Related]

  • 11. NT-pro-BNP in obstructive sleep apnea syndrome is decreased by nasal continuous positive airway pressure.
    Tasci S, Manka R, Scholtyssek S, Lentini S, Troatz C, Stoffel-Wagner B, Lüderitz B.
    Clin Res Cardiol; 2006 Jan 15; 95(1):23-30. PubMed ID: 16598442
    [Abstract] [Full Text] [Related]

  • 12. Atrial natriuretic peptide levels and pulmonary artery pressure awake, at exercise and asleep in obstructive sleep apnoea syndrome.
    Schäfer H, Ehlenz K, Ewig S, Hasper E, Koehler U, Latzelsberger J, Tasci S, Lüderitz B.
    J Sleep Res; 1999 Sep 15; 8(3):205-10. PubMed ID: 10476007
    [Abstract] [Full Text] [Related]

  • 13. Plasma levels of atrial natriuretic factor in moderate to severe obstructive sleep apnea syndrome.
    Lin CC, Tsan KW, Lin CY.
    Sleep; 1993 Jan 15; 16(1):37-9. PubMed ID: 8456234
    [Abstract] [Full Text] [Related]

  • 14. Atrial natriuretic peptide and catecholamines in obstructive sleep apnea syndrome.
    Baruzzi A, Riva R, Cirignotta F, Zucconi M, Cappelli M, Lugaresi E.
    Sleep; 1991 Feb 15; 14(1):83-6. PubMed ID: 1839810
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Influence of moderate alcohol consumption on obstructive sleep apnoea with and without AutoSet nasal CPAP therapy.
    Teschler H, Berthon-Jones M, Wessendorf T, Meyer HJ, Konietzko N.
    Eur Respir J; 1996 Nov 15; 9(11):2371-7. PubMed ID: 8947088
    [Abstract] [Full Text] [Related]

  • 17. Atrial natriuretic peptide levels in the sleep apnoea/hypopnoea syndrome.
    Mackay TW, Fitzpatrick MF, Freestone S, Lee MR, Douglas NJ.
    Thorax; 1994 Sep 15; 49(9):920-1. PubMed ID: 7940435
    [Abstract] [Full Text] [Related]

  • 18. Prescription of nCPAP and nBIPAP in obstructive sleep apnoea syndrome: Italian experience in 105 subjects. A prospective two centre study.
    Resta O, Guido P, Picca V, Sabato R, Rizzi M, Scarpelli F, Sergi M.
    Respir Med; 1998 Jun 15; 92(6):820-7. PubMed ID: 9850365
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Pituitary reactivity, androgens and catecholamines in obstructive sleep apnoea. Effects of continuous positive airway pressure treatment (CPAP).
    Bratel T, Wennlund A, Carlström K.
    Respir Med; 1999 Jan 15; 93(1):1-7. PubMed ID: 10464840
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.